Cardiovascular Impairment in COVID-19: Learning From Current Options for Cardiovascular Anti-Inflammatory Therapy

In December 2019, Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2, occurred in China and has currently led to a global pandemic. In addition to respiratory involvement, COVID-19 was also associated with significant multiple organ dysfunction syndrome (MODS). Cardiovascular impairment has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lun, Zhang, Yang, Zhang, Shuyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203508/
https://www.ncbi.nlm.nih.gov/pubmed/32426374
http://dx.doi.org/10.3389/fcvm.2020.00078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203508/
https://www.ncbi.nlm.nih.gov/pubmed/32426374
http://dx.doi.org/10.3389/fcvm.2020.00078

Ejemplares similares